# Intra-nodal Injection of Gentamicin for the Treatment of Suppurated Cat Scratch Disease's Lymphadenitis

> **NCT03132116** · PHASE3 · COMPLETED · sponsor: **University Hospital, Toulouse** · enrollment: 75 (actual)

## Conditions studied

- Cat-Scratch Disease

## Interventions

- **DRUG:** gentamicin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT03132116
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-31
- **Primary completion:** 2025-08-21
- **Final completion:** 2025-08-21
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2026-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03132116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03132116, "Intra-nodal Injection of Gentamicin for the Treatment of Suppurated Cat Scratch Disease's Lymphadenitis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03132116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*